Nano Stocks

J&J Subsidiary Seeks EU Approval for Nanocrystal Based Schizophrenia Drug

by Kevin Rippey on Dec.07, 2009, under Nanotech Company Info, Pharmaceuticals

Janssen-Cilag a division of Johnson & Johnson (NYSE: JNJ) has submitted a marketing application for paliperidone palmitate (marketed as Invega Sustenna in the US) a once-montly schizophrenia treatment that utilizes Elan’s (NYSE: ELN) Nanocrystal drug delievery system. The treatment was granted approval by the FDA in August. The monthly injection is seen as having certian advantages over oral drug treatments. Specifically, paliperidone palmitate avoids the potential for relapse as result of individual’s failing to take their medication (a common outcome of oral-based schezophrenia treatments).

Full Story: Here

J&J partnered with Elan following a $1 billion investment by the New Jersey health care giant earlier this year. In return for the investment J&J recieved an 18.34% stake in the Dublin based biotech company and rights to teh biotech’s Immunotherapy Program.

Full Story: Here

:, , ,

1 Comment for this entry

  • BelmBruinaner

    Anyone heard about google money pro programm? I accidently came accro this website googlemoneypro
    author claims that this ebook can teach you to earn money with google adwords. What do you think is it real or no. Anyone bought it? I don’t want to loose money again. BTW sorry for offtopic!
    here is website I neeed your opinion

9 Trackbacks / Pingbacks for this entry

Leave a Reply

Looking for something?

Use the form below to search the site:

Still not finding what you're looking for? Drop a comment on a post or contact us so we can take care of it!

Archives

All entries, chronologically...